ARHGAP35 and neoplasm: The tumour burden was abolished in 451Lu-tumour-bearing mice receiving p190RhoGAP siRNA and δD910A/D910A macrophages compared to mice receiving WT macrophages alone or WT macrophages and p190RhoGAP siRNA (Fig. 4a).